PAPER Chipi E, Fruttini D, Salvadori N, Montanucci C, Siena E, Menculini G, Mazzeschi C, Parnetti L
SEARCH RESULTS
300519 RESULTS
PAPER Madison FN, Palin N, Whitaker A, Glasper ER
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Brain Behav Immun. 2022 Nov;106:1-10. Epub 2022 Jul 28 PubMed.PAPER Tu Y, Lin S, Qiao J, Zhuang Y, Zhang P
Identification and characterization of a new variant of apolipoprotein E (apo E-Kochi).
Comput Biol Med. 2022 Sep;148:105901. Epub 2022 Jul 20 PubMed.PAPER Sarik DA, Hill-Rodriguez D, Gattamorta KA, Gonzalez JL, Esteves J, Zamora K, Cordo J
Association of ApoE genetic variants with obstructive sleep apnea in children.
J Pediatr Nurs. 2022;67:34-37. Epub 2022 Jul 28 PubMed.PAPER Karpouzian-Rogers T, Hurley R, Seckin M, Moeller S, Gill N, Zhang H, Coventry C, Nelson M, Weintraub S, Rogalski E, Marsel Mesulam M
Apolipoprotein E Sendai (arginine 145--> proline): a new variant associated with lipoprotein glomerulopathy.
Brain Lang. 2022 Sep;232:105165. Epub 2022 Jul 28 PubMed.PAPER Chuluunbat M, Matsuda D, Fujita K, Otomo M, Otomi Y, Kudo K, Harada M, Izumi Y
Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.
J Neurol Sci. 2022 Sep 15;440:120344. Epub 2022 Jul 19 PubMed.PAPER Robertson FE, Jacova C
Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146--> Glu).
Gerontologist. 2022 Jul 31; PubMed.PAPER Piano ME, Veerhuis N, Edwards J, Traynor V, Carey N
Apolipoprotein E1-Hammersmith (Lys146--> Asn;Arg147--> Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.
Clin Exp Optom. 2022 Aug 1;:1-9. PubMed.PAPER Grall-Zahar I, Rucly S, Billard-Pomares T, Gasnier-Besnardeau K, Al Mouft O, Zahar JR, Zirnhelt I
apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.
Infect Dis Now. 2022 Oct;52(7):403-407. Epub 2022 Jul 30 PubMed.PAPER Strain JF, Brier MR, Tanenbaum A, Gordon BA, McCarthy JE, Dincer A, Marcus DS, Chhatwal JP, Graff-Radford NR, Day GS, la Fougère C, Perrin RJ, Salloway S, Schofield PR, Yakushev I, Ikeuchi T, Vöglein J, Morris JC, Benzinger TL, Bateman RJ, Ances BM, Snyder AZ, Dominantly Inherited Alzheimer Network
Apolipoprotein E1-Hammersmith (Lys146--> Asn;Arg147--> Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.
Neuroimage. 2022 Nov 1;261:119511. Epub 2022 Jul 30 PubMed.PAPER Deng N, Wu YY, Feng Y, Hsieh WC, Song JS, Lin YS, Tseng YH, Liao WJ, Chu YF, Liu YC, Chang EC, Liu CR, Sheu SY, Su MT, Kuo HC, Cohen SN, Cheng TH
Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2204779119. Epub 2022 Aug 1 PubMed.PAPER Douglas NF, Brush J
Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy.
J Gerontol Nurs. 2022 Aug;48(8):6-9. PubMed.PAPER Zhu Y, Chew KY, Wu M, Karawita AC, McCallum G, Steele LE, Yamamoto A, Labzin LI, Yarlagadda T, Khromykh AA, Wang X, Sng JD, Stocks CJ, Xia Y, Kollmann TR, Martino D, Joensuu M, Meunier FA, Balistreri G, Bielefeldt-Ohmann H, Bowen AC, Kicic A, Sly PD, Spann KM, Short KR
Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
PLoS Biol. 2022 Aug;20(8):e3001728. PubMed.PAPER Batzios S, Tal G, DiStasio AT, Peng Y, Charalambous C, Nicolaides P, Kamsteeg EJ, Korman SH, Mandel H, Steinbach PJ, Yi L, Fair SR, Hester ME, Drousiotou A, Kaler SG
Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].
Hum Mol Genet. 2022 Aug 1; PubMed.PAPER Atchison CJ, Moshe M, Brown JC, Whitaker M, Wong NC, Bharath AA, McKendry RA, Darzi A, Ashby D, Donnelly CA, Riley S, Elliott P, Barclay WS, Cooke GS, Ward H
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.
Clin Infect Dis. 2022 Aug 1; PubMed.Current Filters
No filters selected